insights_auto
Hvorfor har MYGN gått ned? 6,88%?
Gå mer i dybdenchevron_right
MYGN:NASDAQ
Myriad Genetics Inc
4,26 USD
arrow_downward
−6,88%(−0,32) 1 D
6. okt., 15:19:23 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for MYGN …
Åpne
4,62 USD
Høy
4,83 USD
Lav
4,22 USD
Markedsverdi
404,38 mill.
Snittvolum
1,99 mill.
Volum
1,14 mill.
52 u høy
8,59 USD
52 u lav
2,74 USD
EPS
−1,20 USD
Beta
1,64
Utestående aksjer
95,65 mill.
Antall ansatte
3k
Åpne
4,62 USD
Høy
4,83 USD
Lav
4,22 USD
Markedsverdi
404,38 mill.
Snittvolum
1,99 mill.
Volum
1,14 mill.
52 u høy
8,59 USD
52 u lav
2,74 USD
EPS
−1,20 USD
Beta
1,64
Utestående aksjer
95,65 mill.
Antall ansatte
3k
Nyhetssaker
Fra nettkilder og nyhetspartnere
AD HOC NEWS
·
for 1 døgn siden
Craig-Hallum raises target for Myriad Genetics stock from USD 4.00 to USD 8.00
Profil
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
Om Myriad Genetics Inc
Administrerende direktørPaul J. Diaz | Paul J. Diaz
Ansatte2,7k
Grunnlagt1991
HovedkontorSalt Lake City, Utah, USA
Sektor-
Nettstedmyriad.com